Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations

Anaplastic thyroid cancer is an extremely lethal malignancy without reliable treatment. BRAFV600E point mutation is common in ATCs, which leads to MAPK signaling activation and is regarded as a therapeutic target. Resveratrol inhibits ATC cell growth, while its impact on BRAF-MAPK signaling remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Meng-Di, Li, Hong, Nie, Jun-Hua, Li, Sheng, Ye, Hai-Shan, Li, Ting-Ting, Wu, Mo-Li, Liu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692422/
https://www.ncbi.nlm.nih.gov/pubmed/36430869
http://dx.doi.org/10.3390/ijms232214385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692422/
https://www.ncbi.nlm.nih.gov/pubmed/36430869
http://dx.doi.org/10.3390/ijms232214385

Ejemplares similares